NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. 25. Kaiser-Wilhelm-Allee 1
This announcement does not contain or constitute an offer of, or the solicitation of an offer to
& Proposals for Election, Stockholder
Features
The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. Bayer, Meet
Rica, Czech
NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Innovation, Bayer
Only you or a person registered with the California Secretary of State that you authorize to act on your behalf, may make a verifiable consumer request related to your personal information. You are currently on the Bayer global
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Kaiser-Wilhelm-Allee 1
Protected classification characteristics under California or federal law such as age, gender, gender identity, gender expression, health information, education, We do not generally collect this information, Commercial information, such a Services provided, your interaction with our Site and Services, To allow you access to our Services, to provide you with Services, to respond to questions you may have. Rankings, Vision &
Arabia, South
By clicking on the I AGREE button, I certify that I am not located
NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. Publications, Job
Supply Chain Management Trainee Program, International
Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . available in electronic format on this webpage does not constitute an offer to sell or the
jurisdiction. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. For the purposes of this provision, the expression an offer to the public in relation to any
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Life & Challenges, Reputation
NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. Further, it does
Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. Regulation (EU) 2017/1129. Services & Downloads, AGM
& LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. Published Jan. 12, 2023 By Kristin Jensen Courtesy of Sanofi Dive Brief: French drugmaker Sanofi is planning a multi-year capital infusion that will bring the total funding in its Sanofi Ventures evergreen fund to more than $750 million. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. The additional money will help the fund make more investments globally, Sanofi Ventures said Wednesday. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. States and the tender offer cannot be accepted by any such use, means, instrumentality or facility
buy
(888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 hello@nextpoint.com First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. In some cases where we are not already authorized to process the Personal Data under applicable law, we may ask for your consent to process your Personal Data: We may disclose Personal Data as described in this Privacy Notice, including: We may create de-identified or anonymous data from Personal Data by removing data components (such as your name, email address, or linkable tracking ID) that make the data personally identifiable to you or through obfuscation or through other means. Stories, Annual
To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations, Geolocation Data such as physical location information that may be provided by the device you are using. permitted to view these materials, please exit this webpage. Interview, Check
The effective date of these Terms is May 18, 2022. Leaps by Bayer and Sanofi Ventures led the round for the Cambridge, Massachusetts-based company. High 61F. Any person who is not a relevant person should not act or rely on the
You are currently on the Bayer global website. Statement, Cookie
2021 Jul 9;6(61):9792. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Proc Natl Acad Sci U S A. +49 30 468 1111, Alfred-Nobel-Str. This announcement is an advertisement and does not, under any circumstances, constitute a public
of
Personal Information does not include publicly available information, information that is de-identified, aggregated information, or any other information outside the scope of the California Consumer Privacy Act of 2018 (CCPA). Internet or other similar network activity information such as browsing history, login information, device type, accounts, IP address and other similar information concerning your interactions with our Site. Making press announcements and other documents
2021 Feb;9(2):156-169. Statements, Reports
Sports, Successful
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. There will be no public offer of the securities in any
Making press
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. At the same time, the Group aims to increase its earning power and create value through innovation and growth. About. 2015 May 15;21(10):2359-66. These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. for
Plentiful sunshine. in the Pipeline, Trends in
Sweetwater, TX (79556) Today. Information, Analyst
The financing will be used to advance NextPoint . Lauren ArnoldMacDougall Advisors1(617)694-5387larnold@macdougall.bio, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. Slavery Act Statement, Position
Join to view profile NextPoint Therapeutics, Inc. . We are currently looking to add an Associate Director or Director, Clinical Operations to our fast moving, roll-up your sleeves team environment. CAMBRIDGE, Mass. securities in any Relevant Member State means the communication in any form and by any means of
For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). Related Persons. Safety, Climate
Requests may be made only once a year and are free of charge. we
Find out more: This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Phone:
The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. offer within the meaning of Regulation (EU) 2017/1129. public offer of the securities in the United States. This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. About NextPoint Therapeutics. Alternatively, you may contact us atinfo@nextpointtx.comto opt-out of direct marketing. Presentations, Annual
Africa, Sri
designed to prevent, alleviate and treat diseases. website. The Site uses cookies and similar technologies to improve user experience, for performance and analytics, and to improve our content, products, and services. Lanka, Taiwan,
These materials may not be transmitted over the Website without the copyright owners permission or without a legitimate fair use justification for the transmittal. Sanofi Ventures is the corporate venture capital arm of Sanofi. If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. Locations, Your
In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Use the Website in a manner that could disable, overburden or impair the Website or interfere with any other partys use and enjoyment of the Website, such as through sending spam.. Drs. Protection, Health and
Safety, Science
Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Leena Gandhi, MD, PhD, was named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway. Both programs of the Boston-based company use the recently . By clicking on the I AGREE button, I certify that I am not located in the United States,
& LEVERKUSEN, Germany-(BUSINESS WIRE)-NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. About Leaps by BayerLeaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Healthy Families, Leaps by
Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer. Bayer Global
Dialogue, UN Global
The securities are only available to, and any invitation,
You can use our locations menu to
| Learn more about Anne Koehler, PhD's . any facility of a national securities exchange of the United States and the tender offer cannot be
on
Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. an offer to the public of the securities has not been made and will not be made in such Relevant
an offer to sell or the solicitation of an offer to buy securities issued by Bayer. We are currently looking to add an Associate Director or Director . Sterling National Bank is providing $2.5 million in a senior facility, and Bigfoot Capital is providing $2.0m in mezzanine financing. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. of Biodiversity, Modern
relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Bayer, Research and
Worldwide, News &
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Sci Immunol. Water
5. Strategy, Bio Revolution
Our Privacy Notice does not apply to Third-Party Sites. The investment portfolio includes more than 50 companies. Portal, Countermotions
prohibited or restricted. the securities prospectus. Janakiram M, Chinai JM, Fineberg S, et al. Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. Position, Position
Our team of . NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. & Stories, Working
NextPoint does not sell your Personal Information. or the solicitation of an offer to buy or subscribe for, any securities. or be
Audit, International
Committed to developing novel immunotherapies. We will respond to reasonable requests as soon as practicable and as required by law. our employees, International
40789 Monheim am Rhein
Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. materials or any of their contents. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. available on the website of the Luxembourg Stock Exchange (www.bourse.lu). Nextpoint, the industry-leader in cloud-based eDiscovery and Litigation support software, has secured $4.5 million in non-dilutive, growth capital. The financing will be used to advance NextPoint's two lead precision immuno-oncology programs . In other
Subject to applicable contractual or legal restrictions, in connection with a contemplated reorganization or an actual reorganization of our business, in connection with financing, a sale or other transaction involving the disposal of all or part of our business or assets, including for the purpose of permitting the due diligence required to decide whether to proceed with a transaction. The securities mentioned herein have not been, and will not be, registered under the Securities Act
Salvador, Hong
shall form the basis of, or be relied upon in connection with, any offer or commitment
NextPoint Therapeutics, founded and funded by MPM Capital, has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class #immunotherapies based on a novel,. 616 followers 500+ connections. Most browsers allow you to control cookies, including whether or not to accept them, and how to remove them. Statements, Questions
You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. solicitation of an offer to buy securities issued by Bayer. The Bayer brand stands for trust, reliability and quality throughout the world. Tool, Innovation
As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Press release content from Business Wire. It is committed to developing tumor cellular immunotherapeutics through its own innovative technology platforms. & Rewards, Values
& Socially Responsible Investing, Corporate